Showing results (191-200 of 760) with videos related to
Sort By:
Pageof 76
Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.Blood Cancer Journal|December 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.British Journal of Haematology|March 25, 2010
Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine modelAjita V Singh, Michael A Palladino, George Kenneth Lloyd, et al.Antioxidants & Redox Signaling|February 17, 2024
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic ChemotherapySelma Cifric, Marcello Turi, Pietro Folino, et al.British Journal of Haematology|January 12, 2011
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancersPaul G Richardson, Constantine S Mitsiades, Jacob P Laubach, et al.Journal of Leukemia (Los Angeles, Calif.)|September 27, 2016
Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid TumorsJooeun Bae, Derin B Keskin, Kristen Cowens, et al.Expert Opinion on Emerging Drugs|March 16, 2007
Emerging drugs in multiple myelomaIrene M Ghobrial, Xavier Leleu, Evdoxia Hatjiharissi, et al.Annals of Hematology|January 24, 2018
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myelomaIris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, et al.Pageof 76